share_log

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5

HC Wainwright & Co.维持对OKYO Pharma的买入,将目标股价上调至5美元
Benzinga ·  01/08 08:17

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $4 to $5.

HC Wainwright & Co. 分析师陈毅维持东洋制药(纳斯达克股票代码:OKYO)的买入并将目标股价从4美元上调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发